(Total Views: 351)
Posted On: 11/10/2020 12:34:47 PM
Post# of 36509
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
From GNBT Twitter:
“With the launch of our subsidiary's new website, nugenerexio.com, we have dedicated a large portion of the site to further explain how our Ii-key #vaccine technology platform is applied in cancer and infectious diseases like triple-negative breast cancer and #COVID19.”
“With the launch of our subsidiary's new website, nugenerexio.com, we have dedicated a large portion of the site to further explain how our Ii-key #vaccine technology platform is applied in cancer and infectious diseases like triple-negative breast cancer and #COVID19.”
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)